Intersect ENT Announces Changes to its Board of Directors
Search jobs
-
Resignation of Anthony Vernon and Appointment of Elisabeth Sandoval-Little -
MENLO PARK, Calif. (BUSINESS WIRE) Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Anthony Vernon has resigned from the Intersect ENT Board of Directors on March 31, 2021. Mr. Vernon has served on the Intersect ENT Board since 2015 and is resigning to pursue other interests. Subsequent to Mr. Vernon’s resignation, the Intersect ENT Board today appointed Elisabeth Sandoval-Little to the Company’s Board. Both changes are effective immediately.